logologo
QuantliQuantli

Incyte Corp

INCY

NASDAQ

Biotechnology

$120.16

USD

-0.36 (-0.30%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $24.41B

Volume 785.7K

Price Target

$99.00$155.00

USD

The 7 analysts offering 1-year price forecasts have a max estimate of $155.00 and a min estimate of $99.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$124.00

+$15.0 vs prior

Implied Upside

+3.2%

+12.5% vs prior

Analyst Covering

7

Unchanged vs prior period

Consensus

Hold

Unchanged vs prior

Signal Quality

Consensus Freshness

50%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$11 Gap

Median $113.00 vs avg $124.00 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Hold

3 Buy

4 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

3

Hold

4

Sell

0

Strong Sell

0

7 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Mitchell S. Kapoor

HC Wainwright & Co.

Buy

Reiterated

1 week ago

Plus
Plus
Plus

Andrew Berens

Leerink Partners

Buy

Maintained

1 week ago

Plus
Plus
Plus

Etzer Darout

BMO Capital

Buy

Maintained

4 weeks ago

Plus
Plus
Plus

Evan Seigerman

BMO Capital

Hold

Maintained

4 weeks ago

Plus
Plus
Plus

Ashwani Verma

UBS

Hold

Maintained

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

RVMD

Revolution Medicines Inc

$203.71

+0.8%

NBIX

Neurocrine Biosciences Inc

$152.72

+1.3%

UTHR

United Therapeutics Corp

$499.73

-0.3%

BIIB

Biogen Inc

$209.83

-0.4%

BMRN

BioMarin Pharmaceutical Inc

$67.36

-1.7%

ALNY

Alnylam Pharmaceuticals Inc

$228.65

+0.7%

BBIO

BridgeBio Pharma Inc

$79.86

-1.7%

MRNA

Moderna Inc

$63.32

-0.5%

EXEL

Exelixis Inc

$51.24

+1.2%

INSM

Insmed Inc

$123.74

-2.0%